Phibro Animal Health (PAHC) Annual Income Statement

Annual · GAAP · USD millions
Access PAHC quarterly income statements →
From Phibro Animal Health through Jun 30 2022, changes in Jun 30 2026's revenue and cost structure provide insight into profitability trends.
Annual Report, GAAP in USD millions
ITEM
(Jun 30 2026)
2026
(Jun 30 2025) (Jun 30 2024) (Jun 30 2023) (Jun 30 2022)
Revenues
Revenue From Contract With Customer Excluding Assessed Tax1,518.09
Total Revenue1,518.09
Costs & Expenses
Cost of Goods and Services Sold1,005.58
Gross Profit0.00
Selling, Administration, Marketing318.12
Depreciation & Amortization105.35
Research & Development24.55
Restructuring, Accretion & Impairment Charges4.87
Other Operating Expense / -Income0.00
Total operating costs including COS0.00
Operating income / -loss194.40
Interest Expense0.00
Interest Expense, Other0.28
Interest Income1.99
Net Interest Expense / -Income-44.43
Foreign Currency Transaction Gain (Loss), before Tax-12.62
Other loss / -income0.00
Total costs & expenses0.00
Income & Taxes
Income / -loss before income taxes137.35
Income taxes expenses / -benefit37.63
Income after income taxes99.72
Net income / -loss of other equity0.00
Income / -loss from continuing operations99.72
Net income / -loss99.72
Income / -loss to shareholder99.72
EBIT92.92
EBITD113.70
EBITDA121.48
Earnings Per Share
Basic EPS (excl. extra items)2.46
Basic Net EPS2.46
Basic shares outstanding (Mill. of Units)40.55
Diluted Net EPS2.43
Diluted average shares (Mill. of Units)40.96
Dividend per share0.48
4 historic quarters locked

Sign in to unlock the full Phibro Animal Health income statement history.

About Phibro Animal Health Corp Annual Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-K filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.